SVLS's investment strategy is focused upon four sectors within the human life sciences industry; biotechnology/biopharmaceuticals, medical devices, healthcare services and technology.
The five funds that the SVLS team advise are able to invest in life sciences businesses at all stages of development. Our five limited partnership funds focus on investing in equity, or near equity securities, in private businesses. We usually take a lead investor position within a strong investment syndicate structured to fully support the business in its objectives.
Geographically, SVLS funds concentrate their investment into businesses based in North America and Western Europe, but will consider investment opportunities in other regions, where there is a well-developed life sciences sector.
SVLS focuses on investments in companies with a very high quality management team and a business model that could provide a strong increase in value. Often this value enhancement can be achieved with the addition of a key technology or technologies protectable by law which allows the business to be developed and shielded from competition. SVLS investments may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market.